Mitotix, Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center deal

Mitotix acquired from the centers an exclusive worldwide license to the natural cell cycle inhibitor p27 for all anti-proliferative therapeutic and diagnostic applications. Mitotix is using the gene a...